These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1370 related items for PubMed ID: 18453021

  • 1. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L, Armstrong J, Buckney S, Assiri M, Cannon M, Holmberg O.
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, Catton P, Crook J, Gospodarowicz MK, McLean M, Milosevic M, Warde P.
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [Abstract] [Full Text] [Related]

  • 3. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P, Piotrowski T, Dymnicka M.
    Neoplasma; 2004 Jan; 51(1):64-9. PubMed ID: 15004663
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [Abstract] [Full Text] [Related]

  • 6. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):141-9. PubMed ID: 16111582
    [Abstract] [Full Text] [Related]

  • 7. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS, Tomé WA, Jaradat H, Raisbeck BM, Ritter MA.
    Acta Oncol; 2006 Sep 01; 45(6):717-27. PubMed ID: 16938815
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M, Lebesque JV, Mijnheer BJ, Damen EM.
    Radiother Oncol; 2004 Nov 01; 73(2):209-18. PubMed ID: 15542168
    [Abstract] [Full Text] [Related]

  • 9. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U, Bogner J, Georg D, Auberger T, Pötter R.
    Strahlenther Onkol; 2005 Jul 01; 181(7):448-55. PubMed ID: 15995838
    [Abstract] [Full Text] [Related]

  • 10. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G, Hancock SL, Boyer AL.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):267-84. PubMed ID: 15093924
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1142-52. PubMed ID: 15939547
    [Abstract] [Full Text] [Related]

  • 16. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Petersen I, McCormick B.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1531-7. PubMed ID: 16198508
    [Abstract] [Full Text] [Related]

  • 17. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L, Ciscognetti N, Martin G, Liuzzi R, Punzo G, Solla R, Farella A, Salvatore M, Pacelli R.
    Med Dosim; 2009 Dec 01; 34(1):75-81. PubMed ID: 19181259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
    Koelbl O, Richter S, Flentje M.
    Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1193-8. PubMed ID: 10613312
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.